Latest Medtech News
Where is funding activity picking up across MedTech? This week’s funding spans surgical robotics, AI-driven cardiovascular care, neurorehabilitation and precision treatment, with several deals focused on turning promising technologies into scalable products. Details follow below.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like these. Subscribe to our Industry Insights for weekly coverage.
Medtronic invests $700M in Cornerstone Robotics, adds Sentire to surgical portfolio
Medtronic is investing approximately $700M in Cornerstone Robotics, gaining rights to distribute its Sentire surgical system in select markets outside the U.S. Sentire will complement Medtronic’s Hugo RAS platform, giving hospitals greater choice across robotic-assisted surgery.
Founder and CEO of Cornerstone Robotics Samuel Au: “Since the founding of Cornerstone Robotics, we have been steadfast in our commitment to innovation, excellence and clinical value,”
Chairman and CEO of Medtronic Geoff Martha
Elucid raises $55M oversubscribed Series D to advance AI cardiovascular platform
Elucid has raised $55M in an oversubscribed Series D, bringing its total funding to approximately $185M. The funding will support commercialization of its AI-powered cardiovascular imaging platform, including FFR-CT and Plaque-IQ™, while advancing clinical studies, AI R&D and strategic partnerships with leading medtech companies.
CEO Kelly Huang: “Analogous to oncology's shift from population-based, one-size treatment, Elucid is applying AI to integrate anatomy, biology, and physiology to bring personalized treatment to coronary artery disease management."
Strolll secures €5M in Innovate UK funding and new investment
Strolll has secured €5M from Innovate UK, alongside additional investment led by IW Capital, to advance its AR-based neurorehabilitation platform. Funding will support AI-powered clinical assessment and StrolllAcute, an AR rehabilitation system designed for acute, bed-bound patients.
Co-Founder and CEO Jorgen Ellis: “This funding will help us accelerate our mission to increase patient engagement, support progression and help clinicians deliver effective neurorehabilitation to a wider patient population."
Türkiye Green Fund invests $10M in Disera for green transformation
Türkiye Green Fund has invested $10M in Disera, marking the fund’s first investment in the healthcare sector. The capital will support Disera’s growth while funding projects focused on reducing carbon emissions, renewable energy, production efficiency, and waste and water management.
General Manager of Disera Kenan Deniz Büyükakman
Tenon Medical prices $3M Private Placement Offering
Tenon Medical has priced a $3M private placement with an institutional investor to support its work in sacro-pelvic disorders. The offering includes common stock or pre-funded warrants alongside additional warrants, with proceeds expected to strengthen the company’s financial position as it advances its medical device platform.
CEO Steven M. Foster
AiM Medical Robotics secures $2M NIH grant to advance MRI-guided brain cancer treatment
AiM Medical Robotics has secured a $2.1M NIH/NCI grant to advance its MRI-compatible neurosurgical robot for precision brain tumor ablation. The funding will support development and a first-in-human feasibility study.
Co-Founder and CEO Gregory Fischer
KOVE Medical raises €1.7M to reduce preterm birth risk
KOVE Medical has raised €1.7M in seed funding to advance its implantable device designed to seal membrane leaks following fetal surgery. The funding will support development toward First-in-Human clinical trials.
Co-Founder and CEO Yannick Devaud